Report Overview
Macular degeneration (AMD) and other retinal diseases are mainly related to long-term and chronic light damage in macular area, choroidal vascular sclerosis, and aging of retinal pigment epithelial cells, often including Lucentis, Eylea, Avastin and other brands.
This report provides a deep insight into the global Macular Degeneration (AMD) and Other Retinal Diseases market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Macular Degeneration (AMD) and Other Retinal Diseases Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Macular Degeneration (AMD) and Other Retinal Diseases market in any manner.
Global Macular Degeneration (AMD) and Other Retinal Diseases Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Merck
Allergan
Santen Pharmaceutical
GlaxoSmithKline Pharmaceuticals
Pfizer
Acucela
Valent Pharmaceuticals
IVERIC
Market Segmentation (by Type)
Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy(DR)
Retinal Vein Occlusion
Wet Age-Related Macular Degeneration (wAMD)
Dry Age-Related Macular Degeneration (dAMD)
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Macular Degeneration (AMD) and Other Retinal Diseases Market
? Overview of the regional outlook of the Macular Degeneration (AMD) and Other Retinal Diseases Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Macular Degeneration (AMD) and Other Retinal Diseases Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Macular Degeneration (AMD) and Other Retinal Diseases
1.2 Key Market Segments
1.2.1 Macular Degeneration (AMD) and Other Retinal Diseases Segment by Type
1.2.2 Macular Degeneration (AMD) and Other Retinal Diseases Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Macular Degeneration (AMD) and Other Retinal Diseases Market Overview
2.1 Global Market Overview
2.1.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Macular Degeneration (AMD) and Other Retinal Diseases Market Competitive Landscape
3.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Manufacturers (2019-2024)
3.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Manufacturers (2019-2024)
3.3 Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Macular Degeneration (AMD) and Other Retinal Diseases Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Macular Degeneration (AMD) and Other Retinal Diseases Sales Sites, Area Served, Product Type
3.6 Macular Degeneration (AMD) and Other Retinal Diseases Market Competitive Situation and Trends
3.6.1 Macular Degeneration (AMD) and Other Retinal Diseases Market Concentration Rate
3.6.2 Global 5 and 10 Largest Macular Degeneration (AMD) and Other Retinal Diseases Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Macular Degeneration (AMD) and Other Retinal Diseases Industry Chain Analysis
4.1 Macular Degeneration (AMD) and Other Retinal Diseases Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Macular Degeneration (AMD) and Other Retinal Diseases Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Macular Degeneration (AMD) and Other Retinal Diseases Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Type (2019-2024)
6.3 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Type (2019-2024)
6.4 Global Macular Degeneration (AMD) and Other Retinal Diseases Price by Type (2019-2024)
7 Macular Degeneration (AMD) and Other Retinal Diseases Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Sales by Application (2019-2024)
7.3 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size (M USD) by Application (2019-2024)
7.4 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Growth Rate by Application (2019-2024)
8 Macular Degeneration (AMD) and Other Retinal Diseases Market Segmentation by Region
8.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Region
8.1.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Region
8.1.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Region
8.2 North America
8.2.1 North America Macular Degeneration (AMD) and Other Retinal Diseases Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Macular Degeneration (AMD) and Other Retinal Diseases Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Macular Degeneration (AMD) and Other Retinal Diseases Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Macular Degeneration (AMD) and Other Retinal Diseases Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Regeneron Pharmaceuticals
9.1.1 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.1.2 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.1.3 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.1.4 Regeneron Pharmaceuticals Business Overview
9.1.5 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases SWOT Analysis
9.1.6 Regeneron Pharmaceuticals Recent Developments
9.2 Bayer HealthCare
9.2.1 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.2.2 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.2.3 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.2.4 Bayer HealthCare Business Overview
9.2.5 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases SWOT Analysis
9.2.6 Bayer HealthCare Recent Developments
9.3 Novartis
9.3.1 Novartis Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.3.2 Novartis Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.3.3 Novartis Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.3.4 Novartis Macular Degeneration (AMD) and Other Retinal Diseases SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Roche
9.4.1 Roche Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.4.2 Roche Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.4.3 Roche Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.4.4 Roche Business Overview
9.4.5 Roche Recent Developments
9.5 Kanghong Pharma
9.5.1 Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.5.2 Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.5.3 Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.5.4 Kanghong Pharma Business Overview
9.5.5 Kanghong Pharma Recent Developments
9.6 Merck
9.6.1 Merck Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.6.2 Merck Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.6.3 Merck Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.6.4 Merck Business Overview
9.6.5 Merck Recent Developments
9.7 Allergan
9.7.1 Allergan Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.7.2 Allergan Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.7.3 Allergan Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.7.4 Allergan Business Overview
9.7.5 Allergan Recent Developments
9.8 Santen Pharmaceutical
9.8.1 Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.8.2 Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.8.3 Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.8.4 Santen Pharmaceutical Business Overview
9.8.5 Santen Pharmaceutical Recent Developments
9.9 GlaxoSmithKline Pharmaceuticals
9.9.1 GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.9.2 GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.9.3 GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.9.4 GlaxoSmithKline Pharmaceuticals Business Overview
9.9.5 GlaxoSmithKline Pharmaceuticals Recent Developments
9.10 Pfizer
9.10.1 Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.10.2 Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.10.3 Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.10.4 Pfizer Business Overview
9.10.5 Pfizer Recent Developments
9.11 Acucela
9.11.1 Acucela Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.11.2 Acucela Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.11.3 Acucela Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.11.4 Acucela Business Overview
9.11.5 Acucela Recent Developments
9.12 Valent Pharmaceuticals
9.12.1 Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.12.2 Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.12.3 Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.12.4 Valent Pharmaceuticals Business Overview
9.12.5 Valent Pharmaceuticals Recent Developments
9.13 IVERIC
9.13.1 IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
9.13.2 IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
9.13.3 IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Product Market Performance
9.13.4 IVERIC Business Overview
9.13.5 IVERIC Recent Developments
10 Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast by Region
10.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast
10.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Country
10.2.3 Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Region
10.2.4 South America Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Macular Degeneration (AMD) and Other Retinal Diseases by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Macular Degeneration (AMD) and Other Retinal Diseases by Type (2025-2030)
11.1.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Macular Degeneration (AMD) and Other Retinal Diseases by Type (2025-2030)
11.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast by Application (2025-2030)
11.2.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) Forecast by Application
11.2.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Macular Degeneration (AMD) and Other Retinal Diseases Market Size Comparison by Region (M USD)
Table 5. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Degeneration (AMD) and Other Retinal Diseases as of 2022)
Table 10. Global Market Macular Degeneration (AMD) and Other Retinal Diseases Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Macular Degeneration (AMD) and Other Retinal Diseases Sales Sites and Area Served
Table 12. Manufacturers Macular Degeneration (AMD) and Other Retinal Diseases Product Type
Table 13. Global Macular Degeneration (AMD) and Other Retinal Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Macular Degeneration (AMD) and Other Retinal Diseases
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Macular Degeneration (AMD) and Other Retinal Diseases Market Challenges
Table 22. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Type (K Units)
Table 23. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Type (M USD)
Table 24. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) by Type (2019-2024)
Table 25. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Type (2019-2024)
Table 26. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size (M USD) by Type (2019-2024)
Table 27. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Share by Type (2019-2024)
Table 28. Global Macular Degeneration (AMD) and Other Retinal Diseases Price (USD/Unit) by Type (2019-2024)
Table 29. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) by Application
Table 30. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Application
Table 31. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Application (2019-2024) & (K Units)
Table 32. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Application (2019-2024)
Table 33. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Application (2019-2024) & (M USD)
Table 34. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Application (2019-2024)
Table 35. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Growth Rate by Application (2019-2024)
Table 36. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales by Region (2019-2024) & (K Units)
Table 37. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Region (2019-2024)
Table 38. North America Macular Degeneration (AMD) and Other Retinal Diseases Sales by Country (2019-2024) & (K Units)
Table 39. Europe Macular Degeneration (AMD) and Other Retinal Diseases Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Sales by Region (2019-2024) & (K Units)
Table 41. South America Macular Degeneration (AMD) and Other Retinal Diseases Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Macular Degeneration (AMD) and Other Retinal Diseases Sales by Region (2019-2024) & (K Units)
Table 43. Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 44. Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 45. Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Regeneron Pharmaceuticals Business Overview
Table 47. Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases SWOT Analysis
Table 48. Regeneron Pharmaceuticals Recent Developments
Table 49. Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 50. Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 51. Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bayer HealthCare Business Overview
Table 53. Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases SWOT Analysis
Table 54. Bayer HealthCare Recent Developments
Table 55. Novartis Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 56. Novartis Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 57. Novartis Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Novartis Macular Degeneration (AMD) and Other Retinal Diseases SWOT Analysis
Table 59. Novartis Business Overview
Table 60. Novartis Recent Developments
Table 61. Roche Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 62. Roche Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 63. Roche Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Roche Business Overview
Table 65. Roche Recent Developments
Table 66. Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 67. Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 68. Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Kanghong Pharma Business Overview
Table 70. Kanghong Pharma Recent Developments
Table 71. Merck Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 72. Merck Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 73. Merck Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Merck Business Overview
Table 75. Merck Recent Developments
Table 76. Allergan Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 77. Allergan Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 78. Allergan Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Allergan Business Overview
Table 80. Allergan Recent Developments
Table 81. Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 82. Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 83. Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Santen Pharmaceutical Business Overview
Table 85. Santen Pharmaceutical Recent Developments
Table 86. GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 87. GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 88. GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. GlaxoSmithKline Pharmaceuticals Business Overview
Table 90. GlaxoSmithKline Pharmaceuticals Recent Developments
Table 91. Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 92. Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 93. Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Pfizer Business Overview
Table 95. Pfizer Recent Developments
Table 96. Acucela Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 97. Acucela Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 98. Acucela Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Acucela Business Overview
Table 100. Acucela Recent Developments
Table 101. Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 102. Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 103. Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Valent Pharmaceuticals Business Overview
Table 105. Valent Pharmaceuticals Recent Developments
Table 106. IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Basic Information
Table 107. IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Product Overview
Table 108. IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. IVERIC Business Overview
Table 110. IVERIC Recent Developments
Table 111. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Macular Degeneration (AMD) and Other Retinal Diseases Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Macular Degeneration (AMD) and Other Retinal Diseases Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Macular Degeneration (AMD) and Other Retinal Diseases Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Macular Degeneration (AMD) and Other Retinal Diseases Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Macular Degeneration (AMD) and Other Retinal Diseases Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Macular Degeneration (AMD) and Other Retinal Diseases
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size (M USD), 2019-2030
Figure 5. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size (M USD) (2019-2030)
Figure 6. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (M USD)
Figure 11. Macular Degeneration (AMD) and Other Retinal Diseases Sales Share by Manufacturers in 2023
Figure 12. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Share by Manufacturers in 2023
Figure 13. Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Macular Degeneration (AMD) and Other Retinal Diseases Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Macular Degeneration (AMD) and Other Retinal Diseases Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Type
Figure 18. Sales Market Share of Macular Degeneration (AMD) and Other Retinal Diseases by Type (2019-2024)
Figure 19. Sales Market Share of Macular Degeneration (AMD) and Other Retinal Diseases by Type in 2023
Figure 20. Market Size Share of Macular Degeneration (AMD) and Other Retinal Diseases by Type (2019-2024)
Figure 21. Market Size Market Share of Macular Degeneration (AMD) and Other Retinal Diseases by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Application
Figure 24. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Application (2019-2024)
Figure 25. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Application in 2023
Figure 26. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Application (2019-2024)
Figure 27. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share by Application in 2023
Figure 28. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Growth Rate by Application (2019-2024)
Figure 29. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Region (2019-2024)
Figure 30. North America Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Country in 2023
Figure 32. U.S. Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Macular Degeneration (AMD) and Other Retinal Diseases Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Macular Degeneration (AMD) and Other Retinal Diseases Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Country in 2023
Figure 37. Germany Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Region in 2023
Figure 44. China Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (K Units)
Figure 50. South America Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Country in 2023
Figure 51. Brazil Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Macular Degeneration (AMD) and Other Retinal Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share Forecast by Type (2025-2030)
Figure 65. Global Macular Degeneration (AMD) and Other Retinal Diseases Sales Forecast by Application (2025-2030)
Figure 66. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Share Forecast by Application (2025-2030)
